$125 | Single User
$250 | Site License
$375 | Enterprise License

Fujirebio Europe N.V. - Strategic SWOT Analysis Review
[Lowest Price Guaranteed: $125]

Published by Global Data: 19 Jan 2016 | 1438 | In Stock
Related Topics: Business

Introduction

Fujirebio Europe N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Fujirebio Europe N.V. (Fujirebio Europe), a subsidiary of Fujirebio Inc, is a global healthcare company. It designs, develops and produces in vitro diagnostic (IVD) testing solutions and markets them worldwide. Its diagnostic products consist of Innotest products for ELISA; INNO-LIA products for autoimmune diseases; INNO-LiPA products for line probe assay; INNO-BIA products for bead-based multiparameter immunoassay, and Lumipulse products for chemiluminescent enzyme immunoassay (CLEIA) system. The company products find application in the treatment of infectious diseases, cancer, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bones.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Fujirebio Europe N.V. - Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    Fujirebio Europe N.V. - Key Facts 6

    Fujirebio Europe N.V. - Key Employees 7

    Fujirebio Europe N.V. - Major Products and Services 8

    Fujirebio Europe N.V. - History 11

    Fujirebio Europe N.V. - Company Statement 14

    Fujirebio Europe N.V. - Locations And Subsidiaries 15

    Head Office 15

    Other Locations & Subsidiaries 15

    Section 2 – Company Analysis 16

    Fujirebio Europe N.V. - Business Description 16

    Fujirebio Europe N.V. - Corporate Strategy 17

    Fujirebio Europe N.V. - SWOT Analysis 18

    SWOT Analysis - Overview 18

    Fujirebio Europe N.V. - Strengths 18

    Strength - Strategic Partnerships and Alliances 18

    Strength - Commitment to Quality 18

    Strength - Established Presence in Markets 18

    Fujirebio Europe N.V. - Weaknesses 19

    Weakness - Single Market Segment 19

    Fujirebio Europe N.V. - Opportunities 20

    Opportunity - Growing IVD Market 20

    Opportunity - New Product Launches 20

    Opportunity - Changing Demographics 20

    Fujirebio Europe N.V. - Threats 21

    Threat - Short Product Life Cycle 21

    Threat - Stiff Competition 21

    Threat - Stringent Regulations 21

    Fujirebio Europe N.V. - Key Competitors 22

    Section 3 – Company’s Lifesciences Financial Deals and Alliances 23

    Fujirebio Europe N.V., Medical Equipment, Deals By Year, 2010 to YTD 2016 23

    Fujirebio Europe N.V., Medical Equipment, Deals By Type, 2010 to YTD 2016 24

    Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 25

    Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 26

    Fujirebio Europe N.V., Recent Deals Summary 27

    Section 4 – Company’s Recent Developments 28

    Mar 05, 2015: Fujirebio Europe Upgrades Its HPV Genotyping Panel With The Launch Of The Inno-Lipa HPV Genotyping Extra II Assay 28

    Section 5 – Appendix 29

    Methodology 29

    About GlobalData 29

    Contact Us 29

    Disclaimer 29

List Of Tables
in Fujirebio Europe N.V. - Strategic SWOT Analysis Review

List of Tables

Fujirebio Europe N.V., Key Facts 6

Fujirebio Europe N.V., Key Employees 7

Fujirebio Europe N.V., Major Products and Services 8

Fujirebio Europe N.V., History 11

Fujirebio Europe N.V., Subsidiaries 15

Fujirebio Europe N.V., Key Competitors 22

Fujirebio Europe N.V., Medical Equipment, Deals By Year, 2010 to YTD 2016 23

Fujirebio Europe N.V., Medical Equipment, Deals By Type, 2010 to YTD 2016 24

Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 25

Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 26

Fujirebio Europe N.V., Recent Deals Summary 27

List Of Figures, Charts and Diagrams
in Fujirebio Europe N.V. - Strategic SWOT Analysis Review

List of Figures

Fujirebio Europe N.V., Medical Equipment, Deals By Year, 2010 to YTD 2016 23

Fujirebio Europe N.V., Medical Equipment, Deals by Type, 2010 to YTD 2016 24

Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 25

Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 26

Additional Details

Publisher

Global Data

Publisher Information

Reference

1438 | GDME1575SA

Number of Pages

29

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Fujirebio Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company w...
16 Aug 2016 by Global Data USD $250 More Info
Fujirebio Diagnostics, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Diagnostics, Inc. (FDI) a subsidiary of Fujirebio Inc. is a healthcare diagnostic c...
16 Aug 2016 by Global Data USD $250 More Info
Fujirebio Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryFujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company w...
11 May 2016 by Global Data USD $250 More Info
Fujirebio Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company w...
13 Apr 2016 by Global Data USD $250 More Info
Fujirebio Diagnostics, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Diagnostics, Inc. (FDI), a subsidiary of Fujirebio, Inc. is a healthcare diagnostic...
13 Apr 2016 by Global Data USD $250 More Info
Fujirebio Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryFujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company w...
10 Mar 2016 by Global Data USD $250 More Info
Fujirebio Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company w...
24 Feb 2016 by Global Data USD $250 More Info
Fujirebio Diagnostics, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Diagnostics, Inc. (FDI), a subsidiary of Fujirebio, Inc. is a healthcare diagnostic...
24 Feb 2016 by Global Data USD $250 More Info
Fujirebio Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company w...
16 Oct 2015 by Global Data USD $250 More Info
Fujirebio Diagnostics, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryFujirebio Diagnostics, Inc. (FDI), a subsidiary of Fujirebio, Inc. is a healthcare diagnostic...
16 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Fujirebio Europe N.V. - Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...